Felix Geser

Summary

Affiliation: University of Innsbruck
Country: Austria

Publications

  1. ncbi request reprint Multiple system atrophy: an update
    Gregor K Wenning
    Department of Neurology, University Hospital, Innsbruck, Austria
    Mov Disord 18:S34-42. 2003
  2. ncbi request reprint Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG)
    Felix Geser
    Clinical Department of Neurology, Innsbruck Medical University, Austria
    Mov Disord 21:179-86. 2006
  3. ncbi request reprint How to diagnose dementia with Lewy bodies: state of the art
    Felix Geser
    Clinical Department of Neurology, Medical University Innsbruck, Austria
    Mov Disord 20:S11-20. 2005
  4. doi request reprint Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry
    Martin Köllensperger
    Clinical Department of Neurology, Innsbruck Medical University, Austria
    Mov Disord 25:2604-12. 2010
  5. ncbi request reprint Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study
    Klaus Seppi
    Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
    Neuroimage 31:240-5. 2006
  6. ncbi request reprint Therapeutic strategies in multiple system atrophy
    Gregor K Wenning
    Innsbruck Medical University, Clinical Department of Neurology, Austria
    Mov Disord 20:S67-76. 2005
  7. ncbi request reprint Failure of neuronal protection by inhibition of glial activation in a rat model of striatonigral degeneration
    Nadia Stefanova
    Neurodegeneration Research Laboratory, Innsbruck MSA Study Group, Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
    J Neurosci Res 78:87-91. 2004
  8. ncbi request reprint Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam
    Felix Geser
    Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Alzheimer s Disease Core Center, Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, PA, 19104 4283, USA
    Acta Neuropathol 115:133-45. 2008
  9. ncbi request reprint Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease
    Nicholas J Brandmeir
    Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Alzheimer s Disease Core Center, Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Acta Neuropathol 115:123-31. 2008
  10. doi request reprint Red flags for multiple system atrophy
    Martin Köllensperger
    Section for Clinical Neurobiology, Department of Neurology, Innsbruck Medical University, Austria
    Mov Disord 23:1093-9. 2008

Collaborators

Detail Information

Publications15

  1. ncbi request reprint Multiple system atrophy: an update
    Gregor K Wenning
    Department of Neurology, University Hospital, Innsbruck, Austria
    Mov Disord 18:S34-42. 2003
    ..Several research groups have been formed in Europe (EMSA-SG, NNIPPS) and United States (NAMSA-SG), providing a framework for coordinated trial activity in MSA...
  2. ncbi request reprint Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG)
    Felix Geser
    Clinical Department of Neurology, Innsbruck Medical University, Austria
    Mov Disord 21:179-86. 2006
    ..Our data contribute to the ongoing validation process of UMSARS, and they facilitate the planning and implementation of future neuroprotective intervention trials...
  3. ncbi request reprint How to diagnose dementia with Lewy bodies: state of the art
    Felix Geser
    Clinical Department of Neurology, Medical University Innsbruck, Austria
    Mov Disord 20:S11-20. 2005
    ..We review the present state of the best practice in the clinical diagnosis of DLB. Future modifications of diagnostic criteria would ideally include the full range of clinical presentations that can be associated with LB disease...
  4. doi request reprint Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry
    Martin Köllensperger
    Clinical Department of Neurology, Innsbruck Medical University, Austria
    Mov Disord 25:2604-12. 2010
    ..The observed differences in diagnostic and therapeutic management including lack of therapy for dysautonomia emphasize the need for future guidelines in these areas...
  5. ncbi request reprint Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study
    Klaus Seppi
    Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
    Neuroimage 31:240-5. 2006
    ....
  6. ncbi request reprint Therapeutic strategies in multiple system atrophy
    Gregor K Wenning
    Innsbruck Medical University, Clinical Department of Neurology, Austria
    Mov Disord 20:S67-76. 2005
    ..Because no drug treatment consistently benefits patients with this disease in the long-term, palliative therapies are all the more important. Novel symptomatic and neuroprotective therapies are urgently required...
  7. ncbi request reprint Failure of neuronal protection by inhibition of glial activation in a rat model of striatonigral degeneration
    Nadia Stefanova
    Neurodegeneration Research Laboratory, Innsbruck MSA Study Group, Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
    J Neurosci Res 78:87-91. 2004
    ..We conclude that despite its astrocytic and microglial suppression, minocycline failed to attenuate lesion-induced neuronal damage in the SND rat model...
  8. ncbi request reprint Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam
    Felix Geser
    Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Alzheimer s Disease Core Center, Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, PA, 19104 4283, USA
    Acta Neuropathol 115:133-45. 2008
    ..Finally, we conclude that the spectrum of TDP-43 proteinopathies should be expanded to include neurodegenerative cognitive and motor diseases, affecting the Chamorro population of Guam...
  9. ncbi request reprint Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease
    Nicholas J Brandmeir
    Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Alzheimer s Disease Core Center, Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Acta Neuropathol 115:123-31. 2008
    ....
  10. doi request reprint Red flags for multiple system atrophy
    Martin Köllensperger
    Section for Clinical Neurobiology, Department of Neurology, Innsbruck Medical University, Austria
    Mov Disord 23:1093-9. 2008
    ..9 (+/-7.0) months earlier than with the Consensus criteria alone. We propose a combination of two out of six red flag categories as additional diagnostic criteria for probable MSA-P...
  11. doi request reprint Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis
    Felix Geser
    Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Alzheimer s Disease Core Center, Institute on Aging, Philadelphia, USA
    Arch Neurol 65:636-41. 2008
    ....
  12. ncbi request reprint Disproportionate antecollis: a warning sign for multiple system atrophy
    Felix Geser
    Mov Disord 22:1986; author reply 1986-7. 2007
  13. ncbi request reprint The 'risus sardonicus' of multiple system atrophy
    Gregor K Wenning
    Mov Disord 18:1211. 2003
  14. ncbi request reprint Health-related quality of life in multiple system atrophy
    Anette Schrag
    Department of Clinical Neurosciences, Royal Free and University College Medical School, London, United Kingdom
    Mov Disord 21:809-15. 2006
    ....
  15. ncbi request reprint Multiple system atrophy
    Gregor K Wenning
    Department of Neurology, University Hospital, A 6020 Innsbruck, Austria
    Lancet Neurol 3:93-103. 2004
    ..Symptomatic therapeutic strategies are still limited; however, several candidate neuroprotective agents have entered phase II and phase III clinical trials...